TAGLIATI, Federico
 Distribuzione geografica
Continente #
NA - Nord America 10.556
AS - Asia 5.046
EU - Europa 2.732
SA - Sud America 734
AF - Africa 120
Continente sconosciuto - Info sul continente non disponibili 119
OC - Oceania 8
Totale 19.315
Nazione #
US - Stati Uniti d'America 10.320
SG - Singapore 1.871
CN - Cina 1.357
DE - Germania 600
VN - Vietnam 592
BR - Brasile 563
IT - Italia 433
UA - Ucraina 432
HK - Hong Kong 373
GB - Regno Unito 303
TR - Turchia 264
FI - Finlandia 239
FR - Francia 164
SE - Svezia 145
RU - Federazione Russa 134
BD - Bangladesh 128
JP - Giappone 119
CA - Canada 113
IN - India 95
PL - Polonia 84
MX - Messico 70
AR - Argentina 64
ID - Indonesia 43
ZA - Sudafrica 42
NL - Olanda 38
IQ - Iraq 37
BE - Belgio 30
ES - Italia 30
PK - Pakistan 30
EC - Ecuador 25
CO - Colombia 21
LT - Lituania 19
UZ - Uzbekistan 19
VE - Venezuela 19
AT - Austria 18
CL - Cile 15
EG - Egitto 15
JM - Giamaica 15
PH - Filippine 15
DZ - Algeria 13
SA - Arabia Saudita 13
JO - Giordania 11
KE - Kenya 11
IE - Irlanda 9
MA - Marocco 9
TN - Tunisia 9
CH - Svizzera 8
LB - Libano 8
MY - Malesia 8
TW - Taiwan 8
UY - Uruguay 8
AL - Albania 7
BO - Bolivia 7
TT - Trinidad e Tobago 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CR - Costa Rica 6
IR - Iran 6
NP - Nepal 6
PY - Paraguay 6
AZ - Azerbaigian 5
GR - Grecia 5
KZ - Kazakistan 5
PE - Perù 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
HN - Honduras 4
PS - Palestinian Territory 4
AM - Armenia 3
DK - Danimarca 3
ET - Etiopia 3
EU - Europa 3
GT - Guatemala 3
IL - Israele 3
LV - Lettonia 3
MD - Moldavia 3
PR - Porto Rico 3
PT - Portogallo 3
RO - Romania 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
SV - El Salvador 3
TH - Thailandia 3
CY - Cipro 2
GA - Gabon 2
KG - Kirghizistan 2
ML - Mali 2
OM - Oman 2
PA - Panama 2
SY - Repubblica araba siriana 2
TG - Togo 2
UG - Uganda 2
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
Totale 19.178
Città #
Ashburn 1.481
Singapore 1.271
Woodbridge 891
San Jose 790
Fairfield 716
Chandler 565
Houston 528
Jacksonville 494
Beijing 452
Santa Clara 432
Ann Arbor 380
Hong Kong 359
Seattle 300
Wilmington 266
Council Bluffs 240
Cambridge 216
Ho Chi Minh City 191
Los Angeles 178
New York 153
Addison 150
Munich 145
Hanoi 138
Nanjing 137
Izmir 134
Dallas 133
Ferrara 120
Tokyo 118
Princeton 99
Lauterbourg 91
Helsinki 88
Milan 87
Boardman 86
Shanghai 80
Warsaw 78
Dearborn 67
São Paulo 66
San Diego 60
Turku 54
Orem 51
Mexico City 48
Shenyang 44
Buffalo 42
Bremen 41
Tianjin 39
Brooklyn 37
Nanchang 36
London 34
Chicago 33
Atlanta 32
Da Nang 32
Denver 32
Montreal 32
Changsha 31
Phoenix 31
Toronto 31
Hebei 29
Johannesburg 29
Brussels 28
Chennai 28
Haiphong 28
Washington 28
Frankfurt am Main 26
Hefei 25
Jinan 25
Manchester 25
Jakarta 24
Mountain View 24
Nuremberg 22
Jiaxing 21
Kunming 20
San Francisco 19
Tappahannock 19
Amsterdam 18
Boston 18
Guangzhou 18
Rome 18
Baghdad 17
Poplar 17
Hải Dương 16
Moscow 16
Stockholm 16
Tashkent 16
Ankara 15
Falls Church 15
Norwalk 15
Brasília 14
Rio de Janeiro 14
Biên Hòa 13
City of London 13
Falkenstein 13
Verona 13
Belo Horizonte 12
Charlotte 12
Redwood City 12
Amman 11
Auburn Hills 11
Bologna 11
Leawood 11
Indiana 10
Mumbai 10
Totale 13.275
Nome #
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 439
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 291
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 285
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 283
Chemical Composition of Essential Oils from Thymus vulgaris, Cymbopogon citratus, and Rosmarinus officinalis, and Their Effects on the HIV-1 Tat Protein Function 283
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression 275
Igf-I influences everolimus activity in medullary thyroid carcinoma 267
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 263
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 263
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 260
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines 254
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 253
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 250
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies 248
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 239
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 238
Functional characterization of a new deletion in CDKN1B 5'-UTR region 237
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 236
Allelic discrimination in the diagnosis of somatic BRAF V600E mutation on fine-needle aspiration biopsies 235
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 231
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 230
Magmas, a Novel Over-Expressed Gene in Pituitary Rat Cell Lines and in Human Pituitary Adenomas: A New Pituitary Biomarker? 227
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 224
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 224
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 222
Growth hormone induces chemoresistance in breast cancer cells 220
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 220
BRAFV600E analysis on fine needle aspiration biopsy increases diagnostic accuracy for papillary thyroid cancer in clinically unsuspected nodules 219
Growth hormone excess promotes breast cancer chemoresistance 219
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 217
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 216
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 216
Therapeutic concentrations of mitotane (o,p′-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model 209
miR-15a and miR-16-1 down-regulation in pituitary adenomas 209
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 209
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 208
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 206
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 206
Magmas, a novel over-expressed gene in Pituitary rat cell lines and in human pituitary adenomas: a new pituitary bio marker? 205
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells 205
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 199
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 196
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 194
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 194
Effects of mTOR inhibitors in the control of non functioning pituitary adenomas cell growth 193
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 192
Utilization of luminescent technology to develop a kinase assay: Cdk4 as a model system 190
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 189
Caffeic Acid Enhances the Anti-Leukemic Effect of Imatinib on Chronic Myeloid Leukemia Cells and Triggers Apoptosis in Cells Sensitive and Resistant to Imatinib 189
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells 187
Cytotoxicity of Isoxazole Curcumin Analogs on Chronic Myeloid Leukemia-Derived K562 Cell Lines Sensitive and Resistant to Imatinib 187
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 186
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 186
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 186
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 184
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 183
Role of complex Cdk4/Cyclin D1 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 183
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 182
Role of Piuitary Tumour Transforming Gene 1 in medullary thyroid carcinoma 179
Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-κB 178
Characterization of Stable Pyrazole Derivatives of Curcumin with Improved Cytotoxicity on Osteosarcoma Cell Lines 173
SHP-1 restrains cell proliferation in human medullary thyroid carcinoma 172
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 171
Effects of pasireotide on bronchial carcinoids in primary culture 171
Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT. 168
Real-time PCR is useful to detect menin gene deletions 167
Evaluation of PKC isoforms expression in thyroid cells lines and effects of a PKC beta II selective inhibitor 167
Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 166
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 165
Role of complex cyclin D1/Cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 163
Thyroid Nodule Screening for Malignancy: A Prospective Study on Ultrasonographic/Clinical Profile, Cytology and BRAF V600E Mutation Evaluation 162
Somatostatin receptor subtype 1 selective activation in human growth hormone- and prolactin-secreting pituitary adenomas: effects on cell viability, growth hormone and prolactin secretion. 161
Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line TT 160
Selected terpenes from leaves of Ocimum basilicum L. induce hemoglobin accumulation in human K562 cells 160
Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2 159
GH protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells 159
mTOR inhibition influences cell viability of human bronchial carcinoids in vitro 157
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function. 155
PGH2 blocks the chemosensitizing effects of COX-2 inhibitors by a NF-KB mediated mechanism 153
Somatostatin inhibits a medullary thyroid carcinoma cell line growth by activating SHP-1 152
Evidence for pituitary tumour transforming gene 1 (PTTG-1) expression and its possible oncogenic role in medullary thyroid carcinoma. 152
PKCδ plays an important in regulating human medullary thyroid carcinoma cell viability 151
mTOR inhibition influences cell viability of medullary thyroid carcinoma primary cultures 146
Somatostatin differentially influences proliferation and gene expression by modulating SHP-1 and cAMP pathways in a human medullary thyroid carcinoma cell line 142
A Central Contribution of TG2 Activity to the Antiproliferative and Pro-Apoptotic Effects of Caffeic Acid in K562 Cells of Human Chronic Myeloid Leukemia 141
α-Pinene, a Main Component of Pinus Essential Oils, Enhances the Expression of Insulin-Sensitive Glucose Transporter Type 4 in Murine Skeletal Muscle Cells 133
PRKCD Is a Target of miR-26a in ACTH Pituitary Adenoma 127
miR-26a regulates cell cycle in ACTH-secreting pituitary adenomas through Protein Kinase C delta 127
IGF-I proliferative effects are inhibited by targeting PKC in human neuroendocrine tumor cells 126
SSTR subtypes expression pattern influences the antiproliferative effects of somatostatin and lanreotide on human medullary thyroid carinomas in vitro 125
Targeting PKC in human pancreatic neuroendocrine tumor cells 123
Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro 121
mTOR inhibition hampers cell viability in selected human medullary thyroid carcinoma primary cultures 121
Validation of a murine model to study deregulated pituitary microRNA 119
miR-26a targets PRKCD in ACTH pituitary adenoma 115
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C  114
null 106
null 92
miR-26a and cell cycle control in ACTH secreting pituitary adenoma 86
Targeting protein kinase C by Enzastaurin restrains proliferation and secretion in human pancreatic endocrine tumors 84
Totale 19.110
Categoria #
all - tutte 84.045
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.045


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022903 0 0 68 20 47 54 48 41 36 87 113 389
2022/20231.192 110 102 63 162 191 170 74 94 134 9 49 34
2023/2024908 60 66 28 19 59 105 23 373 19 13 8 135
2024/20252.397 52 46 192 66 312 328 67 70 343 243 365 313
2025/20267.182 716 302 557 785 1.199 472 967 352 683 737 250 162
2026/2027673 145 338 190 0 0 0 0 0 0 0 0 0
Totale 19.315